The Life Sciences Innovative Manufacturing Fund (LSIMF)

Department for Science, Innovation and Technology is offering a funding call in United Kingdom. Applications are open now and no closing date is given. What it covers is set out below in the issuer's own words.

Apply on the issuer's website

At a glance

Type
Funding
Offered by
Department for Science, Innovation and Technology (Public funding)
Where
United Kingdom
Value
From £1 million to £130 million
Who can apply
Private Sector
Closes
Applications open
How to apply
On the issuer's own website

In the issuer's words

Summary

The Life Sciences Innovative Manufacturing Fund (LSIMF) is a capital grants fund which aims to build resilience for future health emergencies and capitalise on the UK’s world-leading research and development capabilities. The fund will enhance and accelerate affordable access to mature, new and emerging Life Sciences products for both pandemic and non-pandemic scenarios.

LSIMF will provide up to £520 million in capital grants for investment in the manufacture of human medicines and medical technology (including diagnostics, and MedTech products).

This is a new fund from previous UK Government Life Sciences manufacturing funds.

LSIMF is open to all eligible companies, including previous manufacturing grant recipients, as long as the application is for a different project.

Projects with a total cost (including capital expenditure) of at least £8 million are eligible to apply.

The maximum intervention rate (ratio of grant to project costs) is 25%, with the typical intervention rate being 10-20% of your total project costs. For example, for a project with a total cost of £100m, the typical grant awarded might be £10-20m.

More from Department for Science, Innovation and Technology

Similar offers in United Kingdom

All sections

Edition